ALNOV.PA - Novacyt S.A.

Paris - Paris Delayed Price. Currency in EUR
0.502
+0.002 (+0.40%)
As of 3:37PM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close0.500
Open0.500
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.488 - 0.520
52 Week Range0.488 - 0.930
Volume221,491
Avg. Volume130,368
Market Cap18.862M
Beta0.45
PE Ratio (TTM)N/A
EPS (TTM)-0.240
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
  • Business Wire2 months ago

    Novacyt: Update on Unsecured Debt Facility

    AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of the €4.0m unsecured, anti-dilutive debt facility (the “Advance”) from a French institutional investor, into an unsecured Convertible Bond (the “Convertible Bond”) further to the announcement on 30 May 2018. The Convertible Bond will be issued on 30 June 2018 following the successful outcome of the Extraordinary General Meeting (EGM) on 11 June 2018, which granted the Company sufficient authorities to issue equity. The Convertible Bond will be issued in a single tranche with a maturity of three years and bears an annual interest rate of 7.4%.

  • Business Wire2 months ago

    Novacyt Launches New Product in Infectious Mononucleosis

    Regulatory News:

  • Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?
    Simply Wall St.3 months ago

    Novacyt Société Anonyme (EPA:ALNOV): Is Breakeven Near?

    Novacyt Société Anonyme’s (ENXTPA:ALNOV): Novacyt Société Anonyme develops and sells diagnostic products for cancer and infectious diseases. The €25.56M market-cap company announced a latest loss of -€5.44M on 31 DecemberRead More...

  • How Did Novacyt Société Anonyme’s (EPA:ALNOV) Earnings Growth Stack Up Against The Industry?
    Simply Wall St.4 months ago

    How Did Novacyt Société Anonyme’s (EPA:ALNOV) Earnings Growth Stack Up Against The Industry?

    Examining Novacyt Société Anonyme’s (ENXTPA:ALNOV) past track record of performance is an insightful exercise for investors. It allows us to reflect on whether or not the company has met orRead More...

  • Business Wire9 months ago

    Novacyt: Admission and First Day of Dealings on AIM

    Regulatory News: